We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0HFQ market cap is 2.31B. The company's latest EPS is USD -6.1569 and P/E is -5.31.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8M | 75M | 63.18M | 10.29M | 17.16M |
| Operating Income | -107.43M | -23.88M | -56.81M | -115.15M | -164.41M |
| Net Income | -97.34M | -19.93M | -57.8M | -128.72M | -163.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 435.2M | 416.55M | 643.07M | 610.38M | 452.39M |
| Total Liabilities | 30.19M | 19.82M | 286.64M | 348.28M | 364.29M |
| Total Equity | 405.01M | 396.73M | 356.43M | 262.1M | 88.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -69.52M | -14.16M | -45.92M | -73.59M | -120.8M |
| Investing | 131.43M | 94.48M | 38.84M | -394.85M | 144.75M |
| Financing | -4.49M | -879k | 252.3M | 44.02M | -59.3M |
| Market Cap | 2.31B |
| Price to Earnings Ratio | -5.31 |
| Price to Sales Ratio | 50.67 |
| Price to Cash Ratio | 24.17 |
| Price to Book Ratio | 9.87 |
| Dividend Yield | - |
| Shares Outstanding | 26.58M |
| Average Volume (1 week) | 51 |
| Average Volume (1 Month) | 106 |
| 52 Week Change | 0.00% |
| 52 Week High | 86.95 |
| 52 Week Low | 86.95 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Anaptysbio Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.anaptysbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
